RSV Townhall to Discuss Nirsevimab
RSV Townhall to Discuss Nirsevimab Come learn about the newly approved monoclonal antibody, nirsevimab (Beyfortus), to prevent RSV in neonates and young infants at a townhall hosted by the Philadelphia Immunization Program. The townhall will take place over Zoom on Tuesday August 29 at 12pm. Nirsevimab will be...